R&D and innovation tax-relief advisory for Swiss SMEs (patent box, R&D super-deduction, cantonal innovation incentives)
Is the demand real?
Since the Swiss tax reform (STAF/TRAF), cantons offer a patent box and an R&D super-deduction of up to 50 percent on qualifying domestic R&D expense, but most SMEs do not know they qualify or how to document it, so the relief goes unclaimed. The buyer is a profitable tech, biotech, medtech, machine-building, or software company with real R&D spend, paying high cantonal tax, and the savings are large enough (often CHF 20,000 to 200,000+ per year) that a success-fee model is easy to sell. This is a high-value, low-competition niche because generalist Treuhand firms rarely specialize in it.
Growing or fading?
Cantons keep refining innovation incentives and awareness lags the rules, so the unclaimed pool grows. Switzerland's dense base of R&D-heavy SMEs (pharma, medtech, deep tech, machinery) keeps expanding the addressable market.
What people search
Unlock the full research
The competitor teardown, the offer to lead with, the outreach scripts, the lead sources, and the 90 day plan are part of the subscription. Unlock them for this idea and run your own scans.
- Competitor teardown and how to beat each one
- The grand slam offer to lead with
- Outreach scripts that book replies
- Where to source the customers
- The first 90 day plan